tradmap

YI 111, Inc.

$3.04 +0.66%

Data as of close

Consumer Defensive · Retail-Drug Stores And Proprietary Stores

111, Inc. (YI) is a consumer defensive company in the Retail-Drug Stores And Proprietary Stores industry. Shares last traded at $3.04, 71.0% below their 52-week high. Over the past year the stock is down 53.8%. Net profit margin is -0.2%, in line with the peer median of -0.2%. Revenue declined 12.8% year over year.

Market Cap
—
Shares Out
—
EPS (TTM) (per ord. share)
-CN¥0.38
P/E (TTM)*
—
P/S Ratio
—
P/B Ratio
—
Dividend / ord. share
—
Dividend Yield
—
52-Week High
$10.50
52-Week Low
$2.52
Volume (venue)
20
Avg Vol (3m, venue)
555.238

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

111, Inc. reports in CNY: EPS, dividends and financials are shown in CNY as filed, per ordinary share. There is no share count on file for the US listing (a depositary receipt prices at a ratio we do not source), so there is no market cap and no price ratio.

Performance

1W
+1.50%
1M
-14.23%
3M
-24.63%
6M
-53.76%
YTD
+20.83%
1Y
-53.79%

Daily candles · volume · SMA(20)/SMA(50) · split-adjusted · Databento EQUS.MINI. YI split history →

Technicals

RSI (14)
44.16
SMA (50)
$3.38
SMA (200)
$5.02
Price vs SMA50
-9.94%
Price vs SMA200
-39.35%
ATR (14)
$0.13

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
CN¥12.6B
Net Income
-CN¥23M
Gross Margin
5.8%
Operating Margin
-0.0%
Net Margin
-0.2%
Return on Equity
3.2%
Return on Assets
-1.0%
Current Ratio
1.09
Debt / Equity
-2.83
Revenue Growth (YoY)
-12.8%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2025-12-31. Source: SEC EDGAR/XBRL, reported in CNY.

Full financials — revenue, cash flow & debt over time →

Retail-Drug Stores And Proprietary Stores peers

YI vs 5 industry peers (Retail-Drug Stores And Proprietary Stores), by market cap. Data as of close

1–5 of 5
CVSCVS Health$117.0B23.930.281.2%+3.33%
GRDNGuardian Pharmacy Services, Inc.$2.6B39.301.774.5%+2.29%
RDGTRidgetech Inc.$113M—0.86-0.9%+2.41%
PETSPETMED EXPRESS INC$26M—0.15-17.3%-0.42%
YI111, Inc.———-0.2%+0.66%

Source: SEC EDGAR (fundamentals/EPS/dividends, reported in CNY) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.